Document is current

Any future updates will be listed below

1359 NTX-0471, engineered multivalent SIRPa and bispecific SIRPa-antiCCR4 molecules demonstrate superior activity providing path for mRNA expressed <i>in-vivo</i> biologics

Crossref DOI link: https://doi.org/10.1136/jitc-2023-SITC2023.1359

Published Online: 2023-11-02

Published Print: 2023-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark